Intuitive Surgical, Inc. (NASDAQ:ISRG) Short Interest Update

Intuitive Surgical, Inc. (NASDAQ:ISRG) was the target of a significant decline in short interest in October. As of October 15th, there was short interest totalling 3,550,000 shares, a decline of 5.1% from the September 30th total of 3,740,000 shares. Based on an average trading volume of 1,270,000 shares, the short-interest ratio is presently 2.8 days.

Intuitive Surgical Stock Down 1.9 %

Shares of Intuitive Surgical stock opened at $503.84 on Friday. Intuitive Surgical has a twelve month low of $260.17 and a twelve month high of $523.34. The company’s 50 day moving average is $490.01 and its 200 day moving average is $445.70. The company has a market cap of $179.46 billion, a price-to-earnings ratio of 81.00, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, EVP Robert Desantis sold 240 shares of the stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 68,246 shares of company stock worth $33,839,308 over the last quarter. Corporate insiders own 0.80% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently modified their holdings of the company. Creekmur Asset Management LLC increased its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $26,000. Delos Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the last quarter. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. Finally, LRI Investments LLC purchased a new position in shares of Intuitive Surgical in the first quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on ISRG shares. Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Raymond James raised their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.